James Kuo

5.5k total citations
33 papers, 1.2k citations indexed

About

James Kuo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, James Kuo has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in James Kuo's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). James Kuo is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). James Kuo collaborates with scholars based in United States, Australia and Canada. James Kuo's co-authors include Igor Vivanco, Douglas C. Saffran, Daniel Afar, René Hubert, Arthur Raitano, Aya Jakobovits, Emily Chen, Tirone E. David, Susan Armstrong and Chaitan Khosla and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

James Kuo

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Kuo United States 14 378 366 282 155 152 33 1.2k
Rocco Piazza Italy 26 761 2.0× 447 1.2× 310 1.1× 67 0.4× 175 1.2× 137 2.2k
Nae Choon Yoo South Korea 17 320 0.8× 415 1.1× 245 0.9× 81 0.5× 77 0.5× 55 976
Hiroaki Yasumoto Japan 21 460 1.2× 265 0.7× 367 1.3× 72 0.5× 85 0.6× 63 1.2k
Yoshito Takeda Japan 22 614 1.6× 581 1.6× 619 2.2× 201 1.3× 370 2.4× 113 2.0k
Masaaki Higashihara Japan 25 675 1.8× 477 1.3× 243 0.9× 138 0.9× 542 3.6× 127 2.1k
John Williams United States 20 355 0.9× 366 1.0× 229 0.8× 141 0.9× 82 0.5× 41 1.1k
Julia Calzada‐Wack Germany 22 665 1.8× 233 0.6× 177 0.6× 67 0.4× 220 1.4× 40 1.2k
Naoki Ikeda Japan 17 332 0.9× 194 0.5× 182 0.6× 174 1.1× 234 1.5× 66 942
Brad A. Marder United States 13 562 1.5× 174 0.5× 181 0.6× 94 0.6× 221 1.5× 33 1.4k
Gil Bornstein Israel 15 1.1k 2.9× 676 1.8× 207 0.7× 175 1.1× 156 1.0× 33 1.6k

Countries citing papers authored by James Kuo

Since Specialization
Citations

This map shows the geographic impact of James Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kuo more than expected).

Fields of papers citing papers by James Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kuo. The network helps show where James Kuo may publish in the future.

Co-authorship network of co-authors of James Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of James Kuo. A scholar is included among the top collaborators of James Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Kuo. James Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Day, Daphne, John Park, Jermaine Coward, et al.. (2023). A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer. British Journal of Cancer. 129(10). 1608–1618. 4 indexed citations
2.
Yuet, Kai P., Corey W. Liu, Stephen R. Lynch, et al.. (2020). Complete Reconstitution and Deorphanization of the 3 MDa Nocardiosis-Associated Polyketide Synthase. Journal of the American Chemical Society. 142(13). 5952–5957. 30 indexed citations
3.
Kuo, James, Donna M. Graham, Lisa W. Le, et al.. (2020). A Randomized Trial of the Electronic Lung Cancer Symptom Scale for Quality-of-Life Assessment in Patients with Advanced Non-small-Cell Lung Cancer. Current Oncology. 27(2). 156–162. 6 indexed citations
4.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). OA01.06 Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1125–S1126. 3 indexed citations
5.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). OA02.02 Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC. Journal of Thoracic Oncology. 14(10). S208–S208. 30 indexed citations
6.
7.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1191–S1192. 3 indexed citations
8.
Kuo, James. (2017). Immune Checkpoint Inhibitors in the Treatment of Advanced Mucosal Melanoma. PubMed. 4(3). 161–167. 6 indexed citations
9.
Kuo, James, et al.. (2016). Partial In Vitro Reconstitution of an Orphan Polyketide Synthase Associated with Clinical Cases of Nocardiosis. ACS Chemical Biology. 11(9). 2636–2641. 18 indexed citations
10.
Tran, Ben, Anne Hamilton, Lisa G. Horvath, et al.. (2016). First-in-man trial of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) as a continuous intravenous infusion (CIVI), in patients (pt) with advanced solid tumours.. Journal of Clinical Oncology. 34(15_suppl). e14025–e14025. 4 indexed citations
11.
Kuo, James, Carolyn Hawkins, & Desmond Yip. (2015). Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis. Asia Pacific Allergy. 5(4). 234–236. 3 indexed citations
12.
Kuo, James & Paul Craft. (2015). Administration of chemotherapy in patients on dialysis. Anti-Cancer Drugs. 26(7). 779–784. 7 indexed citations
13.
Kuo, James & Chaitan Khosla. (2014). The initiation ketosynthase (FabH) is the sole rate-limiting enzyme of the fatty acid synthase of Synechococcus sp. PCC 7002. Metabolic Engineering. 22. 53–59. 21 indexed citations
14.
Kuo, James, Andrea Tazbirkova, Robert J. Allen, et al.. (2014). Serious hepatic complications of selective internal radiation therapy with yttrium‐90 microsphere radioembolization for unresectable liver tumors. Asia-Pacific Journal of Clinical Oncology. 10(3). 266–272. 8 indexed citations
15.
Kim, Sung Hun, Jafi A. Lipson, Catherine J. Moran, et al.. (2013). Image quality and diagnostic performance of silicone-specific breast MRI. Magnetic Resonance Imaging. 31(9). 1472–1478. 5 indexed citations
16.
Kuo, James, C F Hawkins, & Desmond Yip. (2013). Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions. Internal Medicine Journal. 44(5). 442–449. 5 indexed citations
17.
Afar, Daniel, Igor Vivanco, René Hubert, et al.. (2001). Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.. PubMed. 61(4). 1686–92. 199 indexed citations
18.
David, Tirone E., James Kuo, & Susan Armstrong. (1997). Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body. Journal of Thoracic and Cardiovascular Surgery. 114(5). 766–772. 102 indexed citations
19.
Lin, Chun‐Pin, et al.. (1997). Scanning electron microscopic evaluation of the cleanliness of a new ultrasonic root end preparation.. PubMed. 96(9). 727–33. 3 indexed citations
20.
Tripputi, P., et al.. (1987). Translocation of Oncogene c-sis from Chromosome 22 to Chromosome 17 in a Human Myelogenous Leukemia Cell Line. Acta Haematologica. 77(3). 135–139. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocco Piazza Breakdown of academic impact, for papers by Nae Choon Yoo Breakdown of academic impact, for papers by Hiroaki Yasumoto Breakdown of academic impact, for papers by Yoshito Takeda Breakdown of academic impact, for papers by Masaaki Higashihara Breakdown of academic impact, for papers by John Williams Breakdown of academic impact, for papers by Julia Calzada‐Wack Breakdown of academic impact, for papers by Naoki Ikeda Breakdown of academic impact, for papers by Brad A. Marder Breakdown of academic impact, for papers by Gil Bornstein
Rankless by CCL
2026